
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) Down -1.22%: Here’s What Analysts’ Predictions Are Now.
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) shares, rose in value, with the stock price down by -1.22% to the previous day’s close as strong demand from buyers drove the stock to $507.33. Actively observing the price movement in the recent trading, the stock is buoying the session